Recognition of virus infection and innate host responses to viral gene therapy vectors

Molecular Therapy

Volumn 18, Issue 8, 2010, Pages 1422-1429

  Shayakhmetov, Dmitry M ^a   Di Paolo, Nelson C ^a   Mossman, Karen L ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BACULOVIRUS VECTOR; BETA INTERFERON; CRYOPYRIN; DOUBLE STRANDED DNA; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HERPESVIRUS VECTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LENTIVIRUS VECTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PARVOVIRUS VECTOR; RANTES; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; VIRUS VECTOR;

CELL MEMBRANE; CYTOKINE PRODUCTION; ENDOSOME; HEPATITIS C VIRUS; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFLUENZA VIRUS; INNATE IMMUNITY; MOLECULAR RECOGNITION; NONHUMAN; PARAMYXOVIRUS; REVIEW; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS CELL INTERACTION; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS PARTICLE;

MAMMALIA;

EID: 77955172821     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2010.124     Document Type: Review

References (116)

1. Richman, DD Whitley, RJ and Hayden, FG (2002). Clinical Virology, 2nd edn. ASM Press, Washington DC.
2. Takeuchi, O and Akira, S (2009). Innate immunity to virus infection. Immunol Rev 227: 75-86.
3. Takeda, K and Akira, S (2005). Toll-like receptors in innate immunity. Int Immunol 17: 1-14.
4. Alexopoulou, L, Holt, AC, Medzhitov, R and Flavell, RA (2001). Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732-738.
5. Diebold, SS, Kaisho, T, Hemmi, H, Akira, S and Reis e Sousa, C (2004). Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529-1531.
6. Heil, F, Hemmi, H, Hochrein, H, Ampenberger, F, Kirschning, C, Akira, S et al. (2004). Species-specifc recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303: 1526-1529.
7. Lund, JM, Alexopoulou, L, Sato, A, Karow, M, Adams, NC, Gale, NW et al. (2004). Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci USA 101: 5598-5603.
8. Hemmi, H, Takeuchi, O, Kawai, T, Kaisho, T, Sato, S, Sanjo, H et al. (2000). A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745.
9. Colonna, M, Trinchieri, G and Liu, YJ (2004). Plasmacytoid dendritic cells in immunity. Nat Immunol 5: 1219-1226.
10. Kawai, T and Akira, S (2007). TLR signaling. Semin Immunol 19: 24-32.
11. Tabeta, K, Georgel, P, Janssen, E, Du, X, Hoebe, K, Crozat, K et al. (2004). Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci USA 101: 3516-3521.
12. Lee, HK, Lund, JM, Ramanathan, B, Mizushima, N and Iwasaki, A (2007). Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 315: 1398-1401.
13. Zhu, J, Huang, X and Yang, Y (2007). Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and-independent pathways. J Virol 81: 3170-3180.
14. Iacobelli-Martinez, M and Nemerow, GR (2007). Preferential activation of Toll-like receptor nine by CD46-utilizing adenoviruses. J Virol 81: 1305-1312.
15. Kang, DC, Gopalkrishnan, RV, Wu, Q, Jankowsky, E, Pyle, AM and Fisher, PB (2002). mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc Natl Acad Sci USA 99: 637-642.
16. Yoneyama, M, Kikuchi, M, Natsukawa, T, Shinobu, N, Imaizumi, T, Miyagishi, M et al. (2004). The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5: 730-737.
17. Loo, YM, Fornek, J, Crochet, N, Bajwa, G, Perwitasari, O, Martinez-Sobrido, L et al. (2008). Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 82: 335-345.
18. Yoneyama, M, Kikuchi, M, Matsumoto, K, Imaizumi, T, Miyagishi, M, Taira, K et al. (2005). Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 175: 2851-2858.
19. Kato, H, Takeuchi, O, Mikamo-Satoh, E, Hirai, R, Kawai, T, Matsushita, K et al. (2008). Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 205: 1601-1610.
20. Hornung, V, Ellegast, J, Kim, S, Brzózka, K, Jung, A, Kato, H et al. (2006). 5'-Triphosphate RNA is the ligand for RIG-I. Science 314: 994-997.
21. Pichlmair, A, Schulz, O, Tan, C P, Näslund, TI, Liljeström, P, Weber, F et al. (2006). RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 314: 997-1001.
22. Schmidt, A, Schwerd, T, Hamm, W, Hellmuth, JC, Cui, S, Wenzel, M et al. (2009). 5'-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc Natl Acad Sci USA 106: 12067-12072.
23. Kawai, T, Takahashi, K, Sato, S, Coban, C, Kumar, H, Kato, H et al. (2005). IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat Immunol 6: 981-988.
24. Meylan, E, Curran, J, Hofmann, K, Moradpour, D, Binder, M, Bartenschlager, R et al. (2005). Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167-1172.
25. Seth, RB, Sun, L, Ea, CK and Chen, ZJ (2005). Identifcation and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122: 669-682.
26. Xu, LG, Wang, YY, Han, KJ, Li, LY, Zhai, Z and Shu, HB (2005). VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19: 727-740.
27. Michallet, MC, Meylan, E, Ermolaeva, MA, Vazquez, J, Rebsamen, M, Curran, J et al. (2008). TRADD protein is an essential component of the RIG-like helicase antiviral pathway. Immunity 28: 651-661.
28. Oganesyan, G, Saha, SK, Guo, B, He, JQ, Shahangian, A, Zarnegar, B et al. (2006). Critical role of TRAF3 in the Toll-like receptor-dependent and-independent antiviral response. Nature 439: 208-211.
29. Fitzgerald, KA, McWhirter, SM, Faia, KL, Rowe, DC, Latz, E, Golenbock, DT et al. (2003). IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4: 491-496.
30. Melchjorsen, J, Jensen, SB, Malmgaard, L, Rasmussen, SB, Weber, F, Bowie, AG et al. (2005). Activation of innate defense against a paramyxovirus is mediated by RIG-I and TLR7 and TLR8 in a cell-type-specifc manner. J Virol 79: 12944-12951.
31. Sumpter, R Jr, Loo, YM, Foy, E, Li, K, Yoneyama, M, Fujita, T et al. (2005). Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 79: 2689-2699.
32. Kato, H, Sato, S, Yoneyama, M, Yamamoto, M, Uematsu, S, Matsui, K et al. (2005). Cell type-specifc involvement of RIG-I in antiviral response. Immunity 23: 19-28.
33. Kato, H, Takeuchi, O, Sato, S, Yoneyama, M, Yamamoto, M, Matsui, K et al. (2006). Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101-105.
34. Gitlin, L, Barchet, W, Gilfllan, S, Cella, M, Beutler, B, Flavell, RA et al. (2006). Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci USA 103: 8459-8464.
35. Leung, DW, Prins, KC, Borek, DM, Farahbakhsh, M, Tufariello, JM, Ramanan, P et al. (2010). Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35. Nat Struct Mol Biol 17: 165-172.
36. Leung, DW, Shabman, RS, Farahbakhsh, M, Prins, KC, Borek, DM, Wang, T et al. (2010). Structural and Functional Characterization of Reston Ebola Virus VP35 Interferon Inhibitory Domain. J Mol Biol (epub ahead of print).
37. Kimberlin, CR, Bornholdt, ZA, Li, S, Woods, VL Jr, MacRae, IJ and Saphire, EO (2010). Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression. Proc Natl Acad Sci USA 107: 314-319.
38. Ye, Z and Ting, JP (2008). NLR, the nucleotide-binding domain leucine-rich repeat containing gene family. Curr Opin Immunol 20: 3-9.
39. Ting, JP, Willingham, SB and Bergstralh, DT (2008). NLRs at the intersection of cell death and immunity. Nat Rev Immunol 8: 372-379.
40. Lich, JD and Ting, JP (2007). CATERPILLER (NLR) family members as positive and negative regulators of infammatory responses. Proc Am Thorac Soc 4: 263-266.
41. Sutterwala, FS, Ogura, Y and Flavell, RA (2007). The infammasome in pathogen recognition and infammation. J Leukoc Biol 82: 259-264.
42. Lamkanf, M, Kanneganti, TD, Franchi, L and Núñez, G (2007). Caspase-1 infammasomes in infection and infammation. J Leukoc Biol 82: 220-225.
43. Martinon, F, Mayor, A and Tschopp, J (2009). The infammasomes: guardians of the body. Annu Rev Immunol 27: 229-265.
44. Muruve, DA, Pétrilli, V, Zaiss, AK, White, LR, Clark, SA, Ross, PJ et al. (2008). The infammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452: 103-107.
45. Allen, IC, Scull, MA, Moore, CB, Holl, EK, McElvania-TeKippe, E, Taxman, DJ et al. (2009). The NLRP3 infammasome mediates in vivo innate immunity to infuenza A virus through recognition of viral RNA. Immunity 30: 556-565.
46. Thomas, PG, Dash, P, Aldridge, JR Jr, Ellebedy, AH, Reynolds, C, Funk, AJ et al. (2009). The intracellular sensor NLRP3 mediates key innate and healing responses to infuenza A virus via the regulation of caspase-1. Immunity 30: 566-575.
47. Stetson, DB and Medzhitov, R (2006). Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24: 93-103.
48. Takaoka, A, Wang, Z, Choi, MK, Yanai, H, Negishi, H, Ban, T et al. (2007). DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448: 501-505.
49. Ishii, KJ, Coban, C, Kato, H, Takahashi, K, Torii, Y, Takeshita, F et al. (2006). A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat Immunol 7: 40-48.
50. Roberts, TL, Idris, A, Dunn, JA, Kelly, GM, Burnton, CM, Hodgson, S et al. (2009). HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 323: 1057-1060.
51. Hornung, V, Ablasser, A, Charrel-Dennis, M, Bauernfeind, F, Horvath, G, Caffrey, DR et al. (2009). AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating infammasome with ASC. Nature 458: 514-518.
52. Fernandes-Alnemri, T, Yu, JW, Datta, P, Wu, J and Alnemri, ES (2009). AIM2 activates the infammasome and cell death in response to cytoplasmic DNA. Nature 458: 509-513.
53. Bürckstümmer, T, Baumann, C, Blüml, S, Dixit, E, Dürnberger, G, Jahn, H et al. (2009). An orthogonal proteomic-genomic screen identifes AIM2 as a cytoplasmic DNA sensor for the infammasome. Nat Immunol 10: 266-272.
54. Schroder, K, Muruve, DA and Tschopp, J (2009). Innate immunity: cytoplasmic DNA sensing by the AIM2 infammasome. Curr Biol 19: R262-R265.
55. Chen, Z, Benureau, Y, Rijnbrand, R, Yi, J, Wang, T, Warter, L et al. (2007). GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS. J Virol 81: 964-976.
56. Baril, M, Racine, ME, Penin, F and Lamarre, D (2009). MAVS dimer is a crucial signaling component of innate immunity and the target of hepatitis C virus NS3/4A protease. J Virol 83: 1299-1311.
57. Brunetti-Pierri, N, Palmer, DJ, Beaudet, AL, Carey, KD, Finegold, M and Ng, P (2004). Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates. Hum Gene Ther 15: 35-46.
58. Grandvaux, N, Servant, MJ, tenOever, B, Sen, GC, Balachandran, S, Barber, GN et al. (2002). Transcriptional profling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J Virol 76: 5532-5539.
59. Peters, KL, Smith, HL, Stark, GR and Sen, GC (2002). IRF-3-dependent, NFkappa Band JNK-independent activation of the 561 and IFN-beta genes in response to double-stranded RNA. Proc Natl Acad Sci USA 99: 6322-6327.
60. Collins, SE, Noyce, RS and Mossman, KL (2004). Innate cellular response to virus particle entry requires IRF3 but not virus replication. J Virol 78: 1706-1717.
61. Paladino, P, Cummings, DT, Noyce, RS and Mossman, KL (2006). The IFN-independent response to virus particle entry provides a frst line of antiviral defense that is independent of TLRs and retinoic acid-inducible gene I. J Immunol 177: 8008-8016.
62. Ankel, H, Westra, DF, Welling-Wester, S and Lebon, P (1998). Induction of interferon-alpha by glycoprotein D of herpes simplex virus: a possible role of chemokine receptors. Virology 251: 317-326.
63. Boyle, KA, Pietropaolo, RL and Compton, T (1999). Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway. Mol Cell Biol 19: 3607-3613.
64. Mossman, KL, Macgregor, PF, Rozmus, JJ, Goryachev, AB, Edwards, AM and Smiley, JR (2001). Herpes simplex virus triggers and then disarms a host antiviral response. J Virol 75: 750-758.
65. Netterwald, JR, Jones, TR, Britt, WJ, Yang, SJ, McCrone, IP and Zhu, H (2004). Postattachment events associated with viral entry are necessary for induction of interferon-stimulated genes by human cytomegalovirus. J Virol 78: 6688-6691.
66. Tsitoura, E, Thomas, J, Cuchet, D, Thoinet, K, Mavromara, P and Epstein, AL (2009). Infection with herpes simplex type 1-based amplicon vectors results in an IRF3/7-dependent, TLR-independent activation of the innate antiviral response in primary human fbroblasts. J Gen Virol 90(Pt 9): 2209-2220.
67. Chessler, AD, Ferreira, LR, Chang, TH, Fitzgerald, KA and Burleigh, BA (2008). A novel IFN regulatory factor 3-dependent pathway activated by trypanosomes triggers IFN-beta in macrophages and fbroblasts. J Immunol 181: 7917-7924.
68. Hancock, MH, Mossman, KL and Smiley, JR (2009). Cell fusion-induced activation of interferon-stimulated genes is not required for restriction of a herpes simplex virus VP16/ICP0 mutant in heterokarya formed between permissive and restrictive cells. J Virol 83: 8976-8979.
69. Boehme, KW, Guerrero, M and Compton, T (2006). Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J Immunol 177: 7094-7102.
70. Lachmann, R (2004). Herpes simplex virus-based vectors. Int J Exp Pathol 85: 177-190.
71. Johnson, PA, Miyanohara, A, Levine, F, Cahill, T and Friedmann, T (1992). Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1. J Virol 66: 2952-2965.
72. Ho, DY, Fink, SL, Lawrence, MS, Meier, TJ, Saydam, TC, Dash, R et al. (1995). Herpes simplex virus vector system: analysis of its in vivo and in vitro cytopathic effects. J Neurosci Methods 57: 205-215.
73. Olschowka, JA, Bowers, WJ, Hurley, SD, Mastrangelo, MA and Federoff, HJ (2003). Helper-free HSV-1 amplicons elicit a markedly less robust innate immune response in the CNS. Mol Ther 7: 218-227.
74. Suzuki, M, Chiocca, EA and Saeki, Y (2008). Stable transgene expression from HSV amplicon vectors in the brain: potential involvement of immunoregulatory signals. Mol Ther 16: 1727-1736.
75. Suzuki, M, Chiocca, EA and Saeki, Y (2007). Early STAT1 activation after systemic delivery of HSV amplicon vectors suppresses transcription of the vector-encoded transgene. Mol Ther 15: 2017-2026.
76. Zeier, Z, Aguilar, JS, Lopez, CM, Devi-Rao, GB, Watson, ZL, Baker, HV et al. (2009). A limited innate immune response is induced by a replication-defective herpes simplex virus vector following delivery to the murine central nervous system. J Neurovirol 15: 411-424.
77. Hervas-Stubbs, S, Rueda, P, Lopez, L and Leclerc, C (2007). Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. J Immunol 178: 2361-2369.
78. Boulaire, J, Zhao, Y and Wang, S (2009). Gene expression profling to defne host response to baculoviral transduction in the brain. J Neurochem 109: 1203-1214.
79. Brown, BD, Sitia, G, Annoni, A, Hauben, E, Sergi, LS, Zingale, A et al. (2007). In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance. Blood 109: 2797-2805.
80. Hutchin, ME, Pickles, RJ and Yarbrough, WG (2000). Effciency of adenovirus-mediated gene transfer to oropharyngeal epithelial cells correlates with cellular differentiation and human coxsackie and adenovirus receptor expression. Hum Gene Ther 11: 2365-2375.
81. Raper, SE, Chirmule, N, Lee, FS, Wivel, NA, Bagg, A, Gao, GP et al. (2003). Fatal systemic infammatory response syndrome in a ornithine transcarbamylase defcient patient following adenoviral gene transfer. Mol Genet Metab 80: 148-158.
82. Raper, SE, Yudkoff, M, Chirmule, N, Gao, GP, Nunes, F, Haskal, ZJ et al. (2002). A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase defciency. Hum Gene Ther 13: 163-175.
83. Morral, N, O'Neal, WK, Rice, K, Leland, MM, Piedra, PA, Aguilar-Córdova, E et al. (2002). Lethal toxicity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboons. Hum Gene Ther 13: 143-154.
84. Lozier, JN, Csako, G, Mondoro, TH, Krizek, DM, Metzger, ME, Costello, R et al. (2002). Toxicity of a frst-generation adenoviral vector in rhesus macaques. Hum Gene Ther 13: 113-124.
85. Alemany, R, Suzuki, K and Curiel, DT (2000). Blood clearance rates of adenovirus type 5 in mice. J Gen Virol 81(Pt 11): 2605-2609.
86. Kirn, D (2001). Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned? Gene Ther 8: 89-98.
87. Kirn, D, Martuza, RL and Zwiebel, J (2001). Replication-selective virotherapy for cancer: Biological principles, risk management and future directions. Nat Med 7: 781-787.
88. Tao, N, Gao, G P, Parr, M, Johnston, J, Baradet, T, Wilson, JM et al. (2001). Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver. Mol Ther 3: 28-35.
89. Worgall, S, Wolff, G, Falck-Pedersen, E and Crystal, RG (1997). Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum Gene Ther 8: 37-44.
90. Wolff, G, Worgall, S, van Rooijen, N, Song, WR, Harvey, BG and Crystal, RG (1997). Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ. J Virol 71: 624-629.
91. Lieber, A, He, C Y, Meuse, L, Schowalter, D, Kirillova, I, Winther, B et al. (1997). The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. J Virol 71: 8798-8807.
92. Schnell, MA, Zhang, Y, Tazelaar, J, Gao, GP, Yu, QC, Qian, R et al. (2001). Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. Mol Ther 3(5 Pt 1): 708-722.
93. Zhang, Y, Chirmule, N, Gao, GP, Qian, R, Croyle, M, Joshi, B et al. (2001). Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. Mol Ther 3(5 Pt 1): 697-707.
94. Muruve, DA, Barnes, MJ, Stillman, IE and Libermann, TA (1999). Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum Gene Ther 10: 965-976.
95. Borgland, SL, Bowen, GP, Wong, NC, Libermann, TA and Muruve, DA (2000). Adenovirus vector-induced expression of the C-X-C chemokine IP-10 is mediated through capsid-dependent activation of NF-kappaB. J Virol 74: 3941-3947.
96. Bowen, G P, Borgland, SL, Lam, M, Libermann, TA, Wong, NC and Muruve, DA (2002). Adenovirus vector-induced infammation: capsid-dependent induction of the C-C chemokine RANTES requires NF-kappa B. Hum Gene Ther 13: 367-379.
97. Bhat, NR and Fan, F (2002). Adenovirus infection induces microglial activation: involvement of mitogen-activated protein kinase pathways. Brain Res 948: 93-101.
98. Liu, Q and Muruve, DA (2003). Molecular basis of the infammatory response to adenovirus vectors. Gene Ther 10: 935-940.
99. Reid, T, Galanis, E, Abbruzzese, J, Sze, D, Andrews, J, Romel, L et al. (2001). Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial. Gene Ther 8: 1618-1626.
100. Crystal, RG, Harvey, BG, Wisnivesky, JP, O'Donoghue, KA, Chu, KW, Maroni, J et al. (2002). Analysis of risk factors for local delivery of low-and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions. Hum Gene Ther 13: 65-100. (Pubitemid 34075173)
101. Ben-Gary, H, McKinney, RL, Rosengart, T, Lesser, ML and Crystal, RG (2002). Systemic interleukin-6 responses following administration of adenovirus gene transfer vectors to humans by different routes. Mol Ther 6: 287-297.
102. Mickelson, CA (2000). Department of Health and Human Services National Institutes of Health Recombinant DNA Advisory Committee. Minutes of meeting March 8-10, 2000. Hum Gene Ther 11: 2159-2192.
103. McCoy, RD, Davidson, BL, Roessler, BJ, Huffnagle, GB, Janich, SL, Laing, TJ et al. (1995). Pulmonary infammation induced by incomplete or inactivated adenoviral particles. Hum Gene Ther 6: 1553-1560.
104. Hartman, ZC, Kiang, A, Everett, RS, Serra, D, Yang, XY, Clay, TM et al. (2007). Adenovirus infection triggers a rapid, MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivo. J Virol 81: 1796-1812.
105. Hartman, ZC, Black, EP and Amalftano, A (2007). Adenoviral infection induces a multi-faceted innate cellular immune response that is mediated by the toll-like receptor pathway in A549 cells. Virology 358: 357-372.
106. Basner-Tschakarjan, E, Gaffal, E, O'Keeffe, M, Tormo, D, Limmer, A, Wagner, H et al. (2006). Adenovirus effciently transduces plasmacytoid dendritic cells resulting in TLR9-dependent maturation and IFN-alpha production. J Gene Med 8: 1300-1306.
107. Nociari, M, Ocheretina, O, Schoggins, JW and Falck-Pedersen, E (2007). Sensing infection by adenovirus: Toll-like receptor-independent viral DNA recognition signals activation of the interferon regulatory factor 3 master regulator. J Virol 81: 4145-4157.
108. Fejer, G, Drechsel, L, Liese, J, Schleicher, U, Ruzsics, Z, Imelli, N et al. (2008). Key role of splenic myeloid DCs in the IFN-alphabeta response to adenoviruses in vivo. PLoS Pathog 4: e1000208.
109. Di Paolo, NC, Miao, EA, Iwakura, Y, Murali-Krishna, K, Aderem, A, Flavell, RA et al. (2009). Virus binding to a plasma membrane receptor triggers interleukin-1 alpha-mediated proinfammatory macrophage response in vivo. Immunity 31: 110-121.
110. Wickham, TJ, Mathias, P, Cheresh, DA and Nemerow, GR (1993). Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73: 309-319.
111. Greber, UF, Willetts, M, Webster, P and Helenius, A (1993). Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75: 477-486.
112. McCaffrey, AP, Fawcett, P, Nakai, H, McCaffrey, RL, Ehrhardt, A, Pham, TT et al. (2008). The host response to adenovirus, helper-dependent adenovirus, and adeno-associated virus in mouse liver. Mol Ther 16: 931-941.
113. Hasbrouck, NC and High, KA (2008). AAV-mediated gene transfer for the treatment of hemophilia B: problems and prospects. Gene Ther 15: 870-875.
114. Mingozzi, F and High, KA (2007). Immune responses to AAV in clinical trials. Curr Gene Ther 7: 316-324.
115. Zaiss, AK, Liu, Q, Bowen, GP, Wong, NC, Bartlett, JS and Muruve, DA (2002). Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors. J Virol 76: 4580-4590.
116. Zhu, J, Huang, X and Yang, Y (2009). The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice. J Clin Invest 119: 2388-2398.